クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
TB-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTA | 280-288 | 4°C | |||||
TB-5114-1 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-PE |
||||||
cancer | PE | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AQLANDVVL | 4°C | ||||||
TB-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
||||||
cancer | BV421 | H-2Kd | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SYVKVLHHM | 4°C | ||||||
TB-5104-4 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-BV421 |
||||||
cancer | BV421 | H-2Kd | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SYMLQALCI | 4°C | ||||||
TB-5104-1 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-PE |
||||||
cancer | PE | H-2Kd | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SYMLQALCI | 4°C | ||||||
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQVNSLQTV | 4°C | ||||||
TB-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLPLTVAEV | 4°C | ||||||
TB-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLFLLFSL | 4°C | ||||||
TB-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLFLLFSL | 4°C | ||||||
TB-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
||||||
cancer | BV421 | A*03:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLFGVLRLK | 4°C | ||||||
TB-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQV | 157-165 | 4°C | |||||
TB-0019-4 |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMDGTMSQV | 368-376 | 4°C | |||||
TB-0017-4 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLQELNVTV | 169-177 | 4°C | |||||
TB-0016-4 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLLQETELV | 689-697 | 4°C | |||||
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-5108-4 |
H-2Db Survivin Tetramer-ATFKNWPFL-BV421 |
||||||
cancer | BV421 | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ATFKNWPFL | 20-28 | 4°C | |||||
TB-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
||||||
cancer | BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYILSLEEL | 298-306 | 4°C | |||||
TB-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYILSLEEL | 298-306 | 4°C | |||||
TB-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
||||||
cancer | APC | A*01:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KSDICTDEY | 243-251 | 4°C | |||||
TB-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
||||||
cancer | PE | A*01:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KSDICTDEY | 243-251 | 4°C | |||||
TB-0119-1 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-PE |
||||||
cancer | PE | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LPWHRLFLL | 208-216 | 4°C | |||||
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMFPNAPYL | 126-134 | 4°C | |||||
TS-M081-2 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLGRNSFEV | 264-272 | 4°C | |||||
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TLADFDPRV | 883-891 | 4°C | |||||
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AILALLPAL | 105-133 | 4°C | |||||
TB-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
||||||
cancer | BV421 | A*01:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KSDICTDEY | 243-251 | 4°C | |||||
TS-M073-2 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYLQLVFGI | 156-164 | 4°C | |||||
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLPAIVEL | 402-410 | 4°C | |||||
TS-M112-2 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYRALQLHL | 219-227 | 4°C | |||||
TB-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQVNSLQTV | 4°C | ||||||
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
||||||
cancer | BV421 | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CYASGWGSI | 153-161 | 4°C | |||||
TB-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TB-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
||||||
cancer | BV421 | B*35:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
MPFATPMEA | 94-102 | 4°C | |||||
TB-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0013-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (IMDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-0014-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (ITDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ITDQVPFSV | 209-217 | 4°C | |||||
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLTPKKLQCV | 141-150 | 4°C |
※在庫につきましては2024年03月28日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。